Search

everythinglearnresearchcommunity

for

Search:↓

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Botulinum toxin type A injections are the preferred treatment for Frey's syndrome after parotid surgery.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Medicinal herbs might treat hair loss by affecting genes and pathways related to lipid and glycerophospholipid metabolism.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

Using sunscreen and moisturizers may increase the chance of developing Frontal fibrosing alopecia (FFA), but the exact reason why is still unclear.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Hair, skin, and nails supplement use nearly doubled from 2011 to 2020, with higher usage among young adults, females, and certain ethnic groups.

Treatment type and patch size affect hair regrowth patterns in alopecia areata.

High levels of cortisol in hair are linked to a greater risk of brain aneurysm rupture.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Higher hair levels of zinc and chromium were linked to less cognitive decline in very old people.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Certain medications and conditions increase the risk of intraoperative floppy-iris syndrome.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Maintaining enough zinc may help prevent and manage hair loss.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Classical PCOS types A and B are most common and linked to higher health risks.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Patients at dermatology specialist hospitals had lower death and readmission rates but higher treatment costs.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.